51 MADISON AVE,
NEW YORK , NY, 10010

Rank

Rank Universe

Summary

The fund seeks capital appreciation and current income through investing in the U.S. based companies with a track record of dividends.

The fund is sub-advised by Epoch Investment Partners, Inc with a focus on locating stocks with attractive positive growth in operating cash flow

The investment process starts with a list of companies with a track record of dividend. Then the analyst team looks for companies with improving ca More

Link

Directors

Jan 12, 2024
  • Susan B. Kerley
  • Jacques P. Perold
  • Karen Hammond
  • Alan R. Latshaw
  • Richard S. Trutanic
  • Naim Abou-Jaoude
  • David H. Chow

Chief Compliance Officer

  • Kevin M. Gleason

Fund Manager(s)

Price

  • $ 20.37 ( +0.06 )
    Feb 23, 2024
    Last Close
  • Net Assets
  • $1B
    Mar 25, 2024
  • Holding
  • 85
    Mar 25, 2024
    More

  • 52-Week High/Low
  • $20.37 - $17.97
  • Turnover
  • 25%
  • Expense Ratio
  • 1.15%

Company Name

Holding

JPMorgan Chase & Co. 2.54 %
Eli Lilly & Co. 2.39 %
Broadcom, Inc. 2.36 %
MetLife, Inc. 2.15 %
Bank of America Corp. 2.13 %
Merck & Co., Inc. 2.05 %
AbbVie, Inc. 2.04 %
UnitedHealth Group, Inc. 1.88 %
Cummins, Inc. 1.84 %
Johnson & Johnson 1.82 %
More 1.82 %

Documents

Prospectus

Annual Reports

Performance

YTD

-

3 Year

16.93%

5 Year

17.68%

Best

20.36%

2021

Worst

-6.19%

2022

Alpha

EPLSX S&P 500

Chart +